<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30195948</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-2157</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>44</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>11</Month>                    </PubDate>                </JournalIssue>                <Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title>                <ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.</ArticleTitle>            <Pagination>                <MedlinePgn>1743-1749</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0748-7983(18)31276-9</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2018.08.007</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE">To assess prognostic factors of recurrence of phyllodes tumors (PT) of the breast.</AbstractText>                <AbstractText Label="METHODS">We performed a retrospective, multicentric cohort study, including all patients who underwent breast surgery for grade 1 (benign), 2 (borderline) or 3 (malignant) PT between 2000 and 2016 in five tertiary University hospitals, diagnosed according to World Health Organisation classification.</AbstractText>                <AbstractText Label="RESULTS">230 patients were included: 144 (63%), 60 (26%) and 26 (11%) with grade 1, 2 and 3 PT, respectively. Recurrence occurred in 10 (7%), 7 (12%) and 5 (19%) patients with grade 1, 2 and 3 PT, respectively. In univariate analysis, moderate to severe nuclear stromal pleomorphism (HR 8.00 [95% CI: 1.65-38.73], p &lt; 0.009) was correlated with recurrence in all groups including grade 1 (HR 14.3 [95% CI: 1.29-160], p = 0.031). In multivariate analysis, surgical margin &gt;5 mm, (HR 0.20 [95% CI: 0.06-0.63], p = 0.013) were significantly correlated with less recurrence in all PT grades. For grade 1 PT, there was also significantly less recurrence with surgical margin &gt;5 mm, (HR 0.09 [95% CI: 0.01-0.85], p = 0.047) in multivariate analysis.</AbstractText>                <AbstractText Label="CONCLUSION">The surgical margin should be at least 5 mm whatever the grade of PT. Moderate to severe nuclear stromal pleomorphism identified a subgroup of grade 1 PT with a higher rate of recurrence. This suggests that the WHO classification could be revised with the introduction of nuclear stromal pleomorphism to tailor PT management.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Adam</LastName>                    <ForeName>Marie-José</ForeName>                    <Initials>MJ</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Rennes, Hôpital sud, 16 Bd de Bulgarie, 35000, Rennes, France; Service de Sénologie, CRLC Eugène Marquis, Avenue de Bataille Flandres Dunkerque, 35000, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bendifallah</LastName>                    <ForeName>Sofiane</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tenon, Assistance Publique des Hôpitaux de Paris, 4 Rue de la Chine, 75020, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kalhorpour</LastName>                    <ForeName>Négar</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tenon, Assistance Publique des Hôpitaux de Paris, 4 Rue de la Chine, 75020, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cohen-Steiner</LastName>                    <ForeName>Camille</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tours, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37000, Tours, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ropars</LastName>                    <ForeName>Laetitia</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU d'Angers, 4 Rue Larrey, 49100, Angers, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mahmood</LastName>                    <ForeName>Asma</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU La Pitié Salpêtrière, Assistance Publique des Hôpitaux de Paris, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rousseau</LastName>                    <ForeName>Chloé</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Pharmacologie Clinique, CIC Inserm 1414, CHU de Rennes, Hôpital Pontchaillou, 2, rue Henri Le Guilloux, 35033, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Leveque</LastName>                    <ForeName>Jean</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Rennes, Hôpital sud, 16 Bd de Bulgarie, 35000, Rennes, France; Service de Sénologie, CRLC Eugène Marquis, Avenue de Bataille Flandres Dunkerque, 35000, Rennes, France; INSERM 1242, Chemistry, Oncogenesis, Stress and Signaling, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nyangoh Timoh</LastName>                    <ForeName>Krystel</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Rennes, Hôpital sud, 16 Bd de Bulgarie, 35000, Rennes, France; Service de Sénologie, CRLC Eugène Marquis, Avenue de Bataille Flandres Dunkerque, 35000, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Der Some</LastName>                    <ForeName>Adolphe</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Rennes, Hôpital sud, 16 Bd de Bulgarie, 35000, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ouldamer</LastName>                    <ForeName>Lobna</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tours, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37000, Tours, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Legendre</LastName>                    <ForeName>Guillaume</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU d'Angers, 4 Rue Larrey, 49100, Angers, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ballester</LastName>                    <ForeName>Marcos</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tenon, Assistance Publique des Hôpitaux de Paris, 4 Rue de la Chine, 75020, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Daraï</LastName>                    <ForeName>Emile</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Tenon, Assistance Publique des Hôpitaux de Paris, 4 Rue de la Chine, 75020, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Canlorbe</LastName>                    <ForeName>Geoffroy</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU La Pitié Salpêtrière, Assistance Publique des Hôpitaux de Paris, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lavoue</LastName>                    <ForeName>Vincent</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Service de Gynécologie, CHU de Rennes, Hôpital sud, 16 Bd de Bulgarie, 35000, Rennes, France; Service de Sénologie, CRLC Eugène Marquis, Avenue de Bataille Flandres Dunkerque, 35000, Rennes, France; INSERM 1242, Chemistry, Oncogenesis, Stress and Signaling, Rennes, France. Electronic address: vincent.lavoue@chu-rennes.fr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016448">Multicenter Study</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Eur J Surg Oncol</MedlineTA>            <NlmUniqueID>8504356</NlmUniqueID>            <ISSNLinking>0748-7983</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005602" MajorTopicYN="N">France</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000072662" MajorTopicYN="N">Margins of Excision</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003557" MajorTopicYN="N">Phyllodes Tumor</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">Benign</Keyword>            <Keyword MajorTopicYN="Y">Borderline</Keyword>            <Keyword MajorTopicYN="Y">Malignant</Keyword>            <Keyword MajorTopicYN="Y">Phyllodes breast tumor</Keyword>            <Keyword MajorTopicYN="Y">Prognostic factors</Keyword>            <Keyword MajorTopicYN="Y">Surgery</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30195948</ArticleId>            <ArticleId IdType="pii">S0748-7983(18)31276-9</ArticleId>            <ArticleId IdType="doi">10.1016/j.ejso.2018.08.007</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>